S Corradini, D Krug, I Meattini, C Matuschek… - Critical reviews in …, 2019 - Elsevier
The standard of care for early-stage breast cancer (BC) consists of breast-conserving surgery followed by postoperative irradiation. Recently, the concept of changing the usual …
C Polgár, Z Kahán, O Ivanov, M Chorváth… - Pathology and …, 2022 - por-journal.com
The international radiotherapy (RT) expert panel has revised and updated the RT guidelines that were accepted in 2020 at the 4th Hungarian Breast Cancer Consensus Conference …
J Rupp, C Hadamitzky, C Henkenberens… - Radiation …, 2019 - Springer
Background Arm-lymphedema is a major complication after breast cancer. Recent studies demonstrate the validity of predicting Breast Cancer Related Lymphedema (BCRL) by self …
S Bekeschus, F Saadati… - Clinical and Translational …, 2022 - Wiley Online Library
Despite therapeutic improvements in recent years, breast cancer remains an often fatal disease. In addition, breast cancer ulceration may occur during late stages, further …
M Mäurer, D Schott, M Pizon, S Drozdz, T Wendt… - Current …, 2022 - mdpi.com
Background: Adjuvant radiotherapy (RT) is an integral component of a multidisciplinary treatment strategy for early-stage breast cancer. It significantly reduces the incidence of loco …
JJ Hu, JJ Urbanic, LD Case, C Takita… - Journal of Clinical …, 2018 - ascopubs.org
Purpose This study examined an inflammatory biomarker, high-sensitivity C-reactive protein (hsCRP), in radiotherapy (RT)-induced early adverse skin reactions or toxicities in breast …
Cancer is a major public health concern worldwide; it is the second-highest cause of death in the United States. According to projections of cancer incidence and mortality rates …
CJ Lee, HF Fang, CY Wang, KR Chou… - Supportive Care in …, 2022 - Springer
Background Radiodermatitis is commonly experienced by patients with breast cancer undergoing radiotherapy, affecting their quality of life and potentially leading to cancer …
J Ren, X Jiao, MH Akhtar, MAH Nawaz, N Yang… - Colloid and Interface …, 2023 - Elsevier
Abstract Development of efficient and specialized anti-cancer agent is highly desirable for both basic and clinical research. Herein, a multifunctional organosilica nanoagent (MOCL …